Promoting	O
angiogenesis	O
via	O
manipulation	O
of	O
VEGF	O
responsiveness	O
with	O
notch	O
signaling	O
.	O

Promoting	O
angiogenesis	O
via	O
delivery	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
and	O
other	O
angiogenic	O
factors	O
is	O
both	O
a	O
potential	O
therapy	O
for	O
cardiovascular	B-Anatomical_system
diseases	O
and	O
a	O
critical	O
aspect	O
for	O
tissue	B-Tissue
regeneration	O
.	O

The	O
recent	O
demonstration	O
that	O
VEGF	O
signaling	O
is	O
modulated	O
by	O
the	O
Notch	O
signaling	O
pathway	O
,	O
however	O
,	O
suggests	O
that	O
inhibiting	O
Notch	O
signaling	O
may	O
enhance	O
regional	O
neovascularization	O
,	O
by	O
altering	O
the	O
responsiveness	O
of	O
local	O
endothelial	B-Cell
cells	I-Cell
to	O
angiogenic	O
stimuli	O
.	O

We	O
tested	O
this	O
possibility	O
with	O
in	O
vitro	O
assays	O
using	O
human	O
endothelial	B-Cell
cells	I-Cell
,	O
as	O
well	O
as	O
in	O
a	O
rodent	O
hindlimb	B-Organism_subdivision
ischemia	O
model	O
.	O

Treatment	O
of	O
cultured	O
human	O
endothelial	B-Cell
cells	I-Cell
with	O
DAPT	O
,	O
a	O
gamma	O
secretase	O
inhibitor	O
,	O
increased	O
cell	B-Cell
migration	O
and	O
sprout	B-Tissue
formation	O
in	O
response	O
to	O
VEGF	O
stimulation	O
with	O
a	O
biphasic	O
dependence	O
on	O
DAPT	O
concentration	O
.	O

Further	O
,	O
delivery	O
of	O
an	O
appropriate	O
combination	O
of	O
DAPT	O
and	O
VEGF	O
from	O
an	O
injectable	O
alginate	O
hydrogel	O
system	O
into	O
ischemic	O
hindlimbs	B-Organism_subdivision
led	O
to	O
a	O
faster	O
recovery	O
of	O
blood	B-Organism_substance
flow	O
than	O
VEGF	O
or	O
DAPT	O
alone	O
;	O
perfusion	O
levels	O
reached	O
80	O
%	O
of	O
the	O
normal	O
level	O
by	O
week	O
4	O
with	O
combined	O
DAPT	O
and	O
VEGF	O
delivery	O
.	O

Direct	O
intramuscular	B-Immaterial_anatomical_entity
or	O
intraperitoneal	B-Immaterial_anatomical_entity
injection	O
of	O
DAPT	O
did	O
not	O
result	O
in	O
the	O
same	O
level	O
of	O
improvement	O
,	O
suggesting	O
that	O
appropriate	O
presentation	O
of	O
DAPT	O
(	O
gel	O
delivery	O
)	O
is	O
important	O
for	O
its	O
activity	O
.	O

DAPT	O
delivery	O
from	O
the	O
hydrogels	O
also	O
did	O
not	O
lead	O
to	O
any	O
adverse	O
side	O
effects	O
,	O
in	O
contrast	O
to	O
systemic	O
introduction	O
of	O
DAPT	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
a	O
new	O
approach	O
to	O
promote	O
angiogenesis	O
by	O
controlling	O
Notch	O
signaling	O
,	O
and	O
may	O
provide	O
new	O
options	O
to	O
treat	O
patients	O
with	O
diseases	O
that	O
diminish	O
angiogenic	O
responsiveness	O
.	O

